Redeye return with a research update following BioArctic's Q3 report and recent events, including th...
Redeye comments on Cantargia’s Q3 report, the proposed rights issue of SEK170m and the plans to focu...
Redeye has revised its estimates after Starbreeze's Q3 report.
Some positive signs in Germany, but market still weak '25e-'26e EBIT raised by 11-12%, driven by Ger...
Nettoomsättningen för det tredje kvartalet uppgick till 9,7 MEURO (10,3), vilket motsvarade en minsk...
Redeye updates its estimates following the Q3 2024 report from Precise Biometrics.
Redeye states BeammWave’s report was insignificant, and the customer announced the morning after was...
Redeye saw a report with sales that were lower than our expectations.
Solid Q3, with more sequential improvements '24e-'26e sales down 5-6% on slightly softer orders than...
Redeye comments on the announcement that the current CEO has left.
24% organic sales growth y-o-y Improved gross margin due to price adjustments Opex growth to abate i...
Irisity AB (“Irisity” or “the Company”) is a leading provider of AI-driven video analytics solutions...
Spelbolaget Starbreeze rapporterade ett kvartal något under vår prognos.
Pharma Equity Group (“PEG” or “the Company”) published its Q3 report for 2024 on the 15th of Novembe...
Redeye has a positive view of Kontigo Care’s directed share issue of approximately SEK10.
Trots ett fortsatt tufft marknadsläge även under tredje kvartalet lyckades Elon upprätthålla ett pos...
Björn Borg published its Q3 report for 2024 on the 15th of November, 2024.
Redeye states that while Automotive sales came in as expected, Behavioral Research’s unexpectedly we...
Redeye comments on Dala Energi’s Q3 report, which presented no real drama, although reported earning...
Redeye provides further commentary on the Indian tax authorities’ visit to Truecaller’s India office...
